Skip to main content

Peer Review reports

From: Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

Original Submission
14 Dec 2020 Submitted Original manuscript
17 Dec 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
18 Dec 2020 Editorially accepted
4 Jan 2021 Article published 10.1186/s13063-020-04987-8

You can find further information about peer review here.

Back to article page
\